Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: RXRX) | Delayed: 3.59 -0.05 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.64 | 52 Week High | $ | |||
| Open | $3.54 | 52 Week Low | $ | |||
| Day High | $3.68 | P/E | N/A | |||
| Day Low | $3.53 | EPS | $ | |||
| Volume | 3,167,237 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 66.12 -1.64 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.76 | 52 Week High | $0.45 | |||
| Open | $66.10 | 52 Week Low | $0.37 | |||
| Day High | $68.29 | P/E | N/A | |||
| Day Low | $65.57 | EPS | $-0.31 | |||
| Volume | 727,142 | |||||
